ALDEYRA THERAPEUTICS, INC. Operating Lease Right-of-Use Assets
ALDEYRA THERAPEUTICS, INC. (ALDX) had Operating Lease Right-of-Use Assets of $141.11 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-06
- 2026-06-30: Operating Lease, Right-of-Use Asset $141.11K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $209.26K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $275.86K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $340.98K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $141.11K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $209.26K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $275.86K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $340.98K 10-Q · filed 2025-11-05 |
| 2025-06-30 | $404.66K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $466.94K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $266.95K 10-K · filed 2026-02-27 |
| 2024-09-30 | $329.97K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $391.60K 10-Q · filed 2024-08-01 |
| 2024-03-31 | $451.87K 10-Q · filed 2024-05-02 |
| 2023-12-31 | $510.81K 10-K · filed 2025-02-28 |
| 2023-09-30 | $64.46K 10-Q · filed 2023-11-03 |
| 2023-06-30 | $127.45K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $189.03K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $249.26K 10-K · filed 2024-03-07 |
| 2022-09-30 | $181.94K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $239.87K 10-Q · filed 2022-08-05 |
| 2022-03-31 | $296.50K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $351.86K 10-K · filed 2023-03-09 |
| 2021-09-30 | $406.01K 10-Q · filed 2021-10-28 |
| 2021-06-30 | $118.40K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $175.62K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $233.31K 10-K · filed 2022-03-17 |
| 2020-09-30 | $52.20K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $103.07K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $152.67K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $201.01K 10-K · filed 2021-03-11 |
| 2019-09-30 | $248.16K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $294.17K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $377.92K 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |